Tilbake til søkeresultatene

FRIMED-Klinisk medisin og folkehelse

ACTIVE

Tildelt: kr 0,90 mill.

Prosjektleder:

Prosjektnummer:

166247

Søknadstype:

Prosjektperiode:

2005 - 2007

Active is a prospective randomised trial of autologous chondrocyte transplantation compared with alternative treatments for patients who have had a failed primary treatment for chondral defect(s) in the knee. 660 patients in 14 cenres (12 in the UK, 2 in Norway) will be recruited over 2-3 years. Patients will be randomised to 1. ACT or 2. Alternative treatment(pre-specified by clinician, individually for each patient) The primary outcome measure will be time to cessation of benefit of treatment. Secondary outcomes will be functional knee scores (Lysholm, Cincinatti, IKDC) and Quality of life measures (EQ5D) at intervals up to 10 years post operation. Health economic analysis will include Resource Usage.

Budsjettformål:

FRIMED-Klinisk medisin og folkehelse

Temaer og emner

Ingen temaer knyttet til prosjektet